PARSIPPANY, N.J.--(BUSINESS WIRE)--Melinta Therapeutics, LLC today announced the peer-reviewed publication of data from the completed ReSTORE phase 3 global clinical trial evaluating REZZAYO ® ...
Why mismatched resistance thresholds between CLSI and EUCAST could be masking the true scale of antimicrobial resistance in the environment. How can global standardization fix this problem? Study: ...
WAYNE, Pa.--(BUSINESS WIRE)--The Clinical and Laboratory Standards Institute announces the publication of its annually updated antimicrobial susceptibility testing (AST) supplement M100—Performance ...
Worldwide, cryptococcal meningitis kills up to 180,000 persons annually and is the most common cause of nonviral meningitis in the United States. Besides patients with immunosuppression due to human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results